Vaccinex (VCNX) Stock Statistics & Valuation Metrics

Vaccinex has a market cap or net worth of $1.82M. The enterprise value is ―.

Vaccinex has 2,676,637 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vaccinex’s return on equity (ROE) is 8.76 and return on invested capital (ROIC) is 1108.77%.

The current PE Ratio of Vaccinex is -0.21. Vaccinex’s PEG ratio is >-0.01.

In the last 12 months, Vaccinex had revenue of 570.00K and earned -20.25M in profits. Earnings per share was -43.68.

In the last 12 months, operating cash flow was -15.85M and capital expenditures -22.00K, giving a free cash flow of -15.87M billion.

Vaccinex pays an annual dividend of ―, resulting in a dividend yield of ―

Vaccinex upcoming earnings date is May 19, 2025, TBA Not Confirmed.

Vaccinex as a current ratio of 0.57, with Debt / Equity ratio of -4.47%

In the past 12 months, Vaccinex has paid 0.00 in taxes.

Vaccinex EV to EBITDA ratio is -0.15, with an EV/FCF ratio of -0.17.

Vaccinex has $2.91M in cash and marketable securities with $59.00K in debt, giving a net cash position of -$2.85M billion.

Gross margin is -195775.00%, with operating margin of -4014.91%, and net profit margin of -3552.81%.

The average price target for Vaccinex is ―, which is 11.43% higher than the current price. The consensus rating is ―